Nanoform sets two new near-term business targets for 2022
Insider information Nanoform Finland Plc January 3, 2022 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform sets two new near-term business targets for 2022 Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, today announced two new near-term business targets for 2022. Nanoform’s near-term business targets are as follows, where the two first ones are new, while the two latter ones are re-iterated: · At least 20 new customer non-GMP[1] projects in 2022 (+67% vs 2021 target) · At least 3 new customer GMP projects in 2022 (+200% vs